NPRC/Institute
National Institute of Allergy and
Infectious Diseases, National Institutes of Health; Washington National Primate Research Center, University of Washington; HDT Bio; Fred Hutchinson Cancer Research Center
Infectious Diseases, National Institutes of Health; Washington National Primate Research Center, University of Washington; HDT Bio; Fred Hutchinson Cancer Research Center
Summary of Study
A self-amplifying replicon RNA vaccine elicits protective immunity to COVID-19 and a strong protective response even after antibody levels decreased to undetectable levels.
References
PMID: 35982677 / doi: 10.1101/2022.08.08.503239
Contact Info
Deborah Heydenburg Fuller; Jesse H. Erasmus
Keywords
SARS-CoV-2, replicon RNA vaccine, neutralizing antibody response, pathology, primates
Coronavirus Investigated*
NHP Species
date entered
Study Type